ArticleJournal of pharmaceutical analysis2026
SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients.
Weiyu Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.